Andrew Eisen

发表

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials

S. Siler, T. Parry, B. Howell, 2017, Clinical pharmacology and therapeutics.